Evidence map›Paper›PMID 38274765›Full record

ReviewFrontiers in microbiology2023

Olga Ignatyeva, Darya Tolyneva, Aleksandr Kovalyov, Lorena Matkava, Mikhail Terekhov, Daria Kashtanova, Anzhelika Zagainova, Mikhail Ivanov, Vladimir Yudin, Valentin Makarov and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Potential and Challenges ofFoods (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Olga IgnatyevaCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Darya TolynevaCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Aleksandr KovalyovCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Lorena MatkavaCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Mikhail TerekhovCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Daria KashtanovaCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Anzhelika ZagainovaCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Mikhail IvanovCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Vladimir YudinCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Valentin MakarovCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Anton KeskinovCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Sergey KraevoyCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Sergey YudinCentre for Strategic Planning and Management of Biomedical Health Risks, Federal Biomedical Agency, Moscow, Russia.
Federal Medical-Biological Agency · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: As the field of probiotic research continues to expand, new beneficial strains are being discovered. The Methods: We applied a simple search algorithm using the key words " Results: The review showed that Conclusion:

Indexed as

ChristensenellaChristensenellaceaeinflammatory bowel diseasesmetabolic disordersprobiotics

Identifiers

PMID38274765
PMCPMC10808311
OpenAlexW4390744256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.